Edit |   |
---|---|
Antigenic Specificity | Toxin A, Clostridium difficile (Actoxumab biosimilar) |
Clone | Actoxumab |
Host Species | Recombinant |
Reactive Species | n/a |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FuncS, IF, Neut, ELISA, FCM, IP, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Clostridium Difficile Toxin A Recombinant Antibody. Actoxumab is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficile infection. This drug, along with bezlotoxumab, was developed through Phase II efficacy trials by a partnership between Medarex Inc and MassBiologics of the University of Massachusetts Medical School. |
Immunogen | n/a |
Other Names | Anti-Toxin A Recombinant Antibody, Research Grade Actoxumab, Anti-Clostridium Difficile Toxin A Recombinant Antibody, CDA 1, MBL-CDA1, Antibody Drug Analogues, Monoclonal Antibody, YR1272, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1245634-25-6 |
Catalog # | YR1272 |
Price | please inquire |
Order / More Info | Toxin A, Clostridium difficile (Actoxumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |